Study finds diet-derived trans-vaccenic acid boosts anti-tumor immunity

Dietary components that impact anti-tumor immunity.

Optimi Health Celebrates Encouraging Results from the MAPS Phase 3 MDMA-Assisted Therapy Clinical Trial – Psychedelic Alpha

VANCOUVER, British Columbia, Sept. 14, 2023 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a Canadian psychedelics drug research and formulation

September 14, 2023

Novel Drug for Chronic Inducible Urticaria Delivers in Mid-Stage Trial

BOSTON — Treatment with an investigational anti-KIT monoclonal antibody induced clinically meaningful responses in the two most common forms of chronic inducible urticaria, a dose-ranging

October 30, 2024

NTU spin-off teams up with Osler Group to offer early dementia detection tool

Nanyang Technological University, Singapore (NTU Singapore) spin-off company Gray Matter Solutions is partnering with Osler Group, a premium health and wellness organization in Singapore, to

February 4, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.